Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+93.1%
5Y CAGR+26.4%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+93.1%/yr
vs +17.3%/yr prior
5Y CAGR
+26.4%/yr
Recent acceleration
Acceleration
+75.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$737.06M+88.0%
2024$392.10M+100.2%
2023$195.81M+91.4%
2022$102.30M-37.7%
2021$164.16M-28.0%
2020$228.06M+318.9%
2019$54.44M+0.7%
2018$54.06M+30.2%
2017$41.54M+26.1%
2016$32.94M-